Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Companyâs services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļDGX
āļāļ·āđāļāļāļĢāļīāļĐāļąāļQuest Diagnostics Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 17, 1996
āļāđāļāļāļąāđāļāđāļĄāļ·āđāļ1996
āļāļĩāļāļĩāđāļMr. James E. (Jim) Davis
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ45000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļDec 17
āļāļĩāđāļāļĒāļđāđ500 Plaza Drive
āđāļĄāļ·āļāļSECAUCUS
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNYSE Consolidated
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ07094
āđāļāļĢāļĻāļąāļāļāđ19735202700
āđāļ§āđāļāđāļāļāđhttps://www.questdiagnostics.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļDGX
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 17, 1996
āļāđāļāļāļąāđāļāđāļĄāļ·āđāļ1996
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
Mr. Gary M. Pfeiffer
Independent Director
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Ms. Vicky B. Gregg
Independent Director
Mr. Karthik Kuppusamy
Senior Vice President - Clinical Solutions
Senior Vice President - Clinical Solutions
Ms. Denise M. Morrison
Independent Director
Ms. Tracey C. Doi
Independent Director
Mr. Robert B. (Rob) Carter
Mr. Robert B. (Rob) Carter
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
Mr. Gary M. Pfeiffer
Independent Director
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Ms. Vicky B. Gregg
Independent Director
iShares U.S. Healthcare Providers ETF
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
Madison Dividend Value ETF
First Trust Total US Market AlphaDEX ETF
SPDR S&P Health Care Services ETF
Invesco Bloomberg MVP Multi-Factor ETF
Invesco S&P 500 Equal Weight Health Care ETF
iShares Health Innovation Active ETF
First Trust Health Care Alphadex Fund
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Alger Mid Cap 40 ETF
āļŠāļąāļāļŠāđāļ§āļ3.34%
iShares U.S. Healthcare Providers ETF
āļŠāļąāļāļŠāđāļ§āļ3.17%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
āļŠāļąāļāļŠāđāļ§āļ2.99%
Madison Dividend Value ETF
āļŠāļąāļāļŠāđāļ§āļ2.89%
First Trust Total US Market AlphaDEX ETF
SPDR S&P Health Care Services ETF
āļŠāļąāļāļŠāđāļ§āļ1.94%
Invesco Bloomberg MVP Multi-Factor ETF
āļŠāļąāļāļŠāđāļ§āļ1.93%
Invesco S&P 500 Equal Weight Health Care ETF
āļŠāļąāļāļŠāđāļ§āļ1.68%
iShares Health Innovation Active ETF
āļŠāļąāļāļŠāđāļ§āļ1.45%
First Trust Health Care Alphadex Fund
āļŠāļąāļāļŠāđāļ§āļ1.4%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
1.56B
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jan 29, 2025 going ex on Jan 14, 2025
DGX.NB Final Cash Dividend of gross USD 0.75 paid on Oct 21, 2024 going ex on Oct 04, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 22, 2024 going ex on Jul 08, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 22, 2024 going ex on Apr 05, 2024
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 31, 2024 going ex on Jan 16, 2024
DGX.NB Final Cash Dividend of gross USD 0.71 paid on Oct 23, 2023 going ex on Oct 05, 2023 with reinvestment option
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Jul 25, 2023 going ex on Jul 10, 2023 with reinvestment option
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Apr 24, 2023 going ex on Apr 06, 2023 with reinvestment option
DGX.NB Interim Cash Dividend of gross USD 0.66 paid on Feb 01, 2023 going ex on Jan 17, 2023
DGX.NB Final Cash Dividend of gross USD 0.66 paid on Oct 19, 2022 going ex on Oct 03, 2022
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ